Clinical Trials List
Protocol NumberXL184-308
2013-11-01 - 2016-12-31
Phase III
Terminated3
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yu-Chieh Tsai Division of Hematology & Oncology
- Yeong-Shiau Pu Division of Hematology & Oncology
- - - Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 熊小澐 Division of Radiology
- Cheng-Kuang Yang Division of Urology
- Jian-Ri Li Division of Urology
- Chuan-Shu Chen Division of Urology
- Shian-Shiang Wang Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yi-Hsiu Huang Division of Urology
- Yen-Hwa Chang Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
650 participants
